Inactivation of the DNA repair gene O6‐methylguanine‐DNA methyltransferase by promoter hypermethylation and its relationship to aflatoxin B1‐DNA adducts and p53 mutation in hepatocellular carcinoma
Open Access
- 21 November 2002
- journal article
- carcinogenesis
- Published by Wiley in International Journal of Cancer
- Vol. 103 (4) , 440-444
- https://doi.org/10.1002/ijc.10852
Abstract
O6‐methylguanine‐DNA methyltransferase (MGMT) is a repair protein that specifically removes promutagenic alkyl groups from the O6 position of guanine in DNA. MGMT is transcriptionally silenced by promoter hypermethylation in several human cancers. Methylation‐specific PCR (MSP) was used to analyze the MGMT promoter methylation status of 83 hepatocellular carcinomas (HCC) and 2 HCC cell lines (HepG2 and Hep3B). Hypermethylation was detected in 32 of 83 (39%) HCC tissues, but it was not found in either HCC cell line. We also analyzed MGMT expression by immunohistochemical analysis of HCC tissue samples. The presence of aberrant hypermethylation was associated with loss of MGMT protein. The relationship between methylation status and risk factors and tumor markers including environmental exposure to aflatoxin B1 (AFB1), measured as DNA adducts, and status of tumor suppressor gene p53 was also investigated. A statistically significant association was found between MGMT promoter hypermethylation and high level of AFB1‐DNA adducts in tumor tissues (OR = 5.05, 95% CI = 1.29–19.73). A significant association was also found between methylation and p53 mutation status (OR = 2.97, 95% CI = 1.09–8.11). These results suggest that epigenetic inactivation of MGMT plays an important role in the development of HCC and exposure to environmental carcinogens may be related to altered methylation of genes involved in cancer development. The role of chemical carcinogens in hypermethylation needs further investigation.Keywords
This publication has 20 references indexed in Scilit:
- High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1–DNA adduct levels in human hepatocellular carcinomaMolecular Carcinogenesis, 2002
- DNA methylation, methyltransferases, and cancerOncogene, 2001
- The global burden of cancerSeminars in Cancer Biology, 1998
- Methylation of Discrete Regions of the O6-Methylguanine DNA Methyltransferase (MGMT) CpG Island Is Associated with Heterochromatinization of the MGMT Transcription Start Site and Silencing of the GeneMolecular and Cellular Biology, 1997
- Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.Proceedings of the National Academy of Sciences, 1996
- Smoking-related increase in O6-alkylguanine-DNA alkyltransferase activity in human lung tissueCarcinogenesis: Integrative Cancer Research, 1994
- O6-Methylguanine-DNA methyltransferase activity in human tumorsCarcinogenesis: Integrative Cancer Research, 1992
- O6-Methylguanine-DNA methyltransferase activity in human liver tumorsCarcinogenesis: Integrative Cancer Research, 1991
- Chemical carcinogen-induced decreases in genomic 5-methyldeoxycytidine content of normal human bronchial epithelial cells.Proceedings of the National Academy of Sciences, 1987
- Comparison of O6-alkylguanine-DNA alkyltransferase activity based on cellular DNA content in human, rat and mouse tissuesCarcinogenesis: Integrative Cancer Research, 1986